Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Peoples Bancorp
PEBO
$1.42B
| $3.41M | 0.01% |
101,516
+87,271
| +613% | +$2.77M |
|
|
BOLD
1877
DELISTED
Audentes Therapeutics, Inc
BOLD
| $3.4M | 0.01% |
121,275
-60,095
| -33% | -$1.3M |
|
1878
Illinois Tool Works
ITW
$80.2B
| $3.39M | 0.01% |
22,921
-50,293
| -69% | -$7.15M |
|
1879
iShares Select Dividend ETF
DVY
$23.8B
| $3.39M | 0.01% |
36,165
+2,168
| +6% | +$201K |
|
1880
Seres Therapeutics
MCRB
$49.7M
| $3.38M | 0.01% |
10,537
+1,819
| +21% | +$497K |
|
1881
CALL
Conagra Brands
CAG
$7.71B
| $3.37M | 0.01% |
+100,000
| New | +$3.4M |
|
|
DYNC
1882
DELISTED
Vistra Energy Corp.
DYNC
| $3.37M | 0.01% |
50,000
| – | – |
|
1883
Kura Oncology
KURA
$1.16B
| $3.35M | 0.01% |
+223,916
| New | +$2.1M |
|
1884
BBVA Argentina
BBAR
$2.98B
| $3.33M | 0.01% |
163,462
-163,714
| -50% | -$2.83M |
|
|
BLD
1885
DELISTED
TopBuild
BLD
| $3.33M | 0.01% |
51,069
+12,855
| +34% | +$727K |
|
1886
Four Corners Property Trust
FCPT
$2.78B
| $3.33M | 0.01% |
133,490
-601,186
| -82% | -$15.1M |
|
1887
Usana Health Sciences
USNA
$256M
| $3.33M | 0.01% |
57,668
-23,401
| -29% | -$1.38M |
|
|
EGIO
1888
DELISTED
Edgio, Inc. Common Stock
EGIO
| $3.32M | 0.01% |
20,934
+9,829
| +89% | +$1.38M |
|
|
VISN
1889
CALL
Vistance Networks Inc
VISN
$2.65B
| $3.32M | 0.01% |
+100,000
| New | +$3.42M |
|
1890
CVR Energy
CVI
$3.92B
| $3.32M | 0.01% |
128,232
-367,627
| -74% | -$7.82M |
|
|
AKRX
1891
PUT
DELISTED
Akorn Inc
AKRX
| $3.32M | 0.01% |
+100,000
| New | +$3.32M |
|
1892
CareTrust REIT
CTRE
$9.34B
| $3.31M | 0.01% |
173,678
-830,941
| -83% | -$15.6M |
|
|
HOLX
1893
CALL
DELISTED
Hologic
HOLX
| $3.3M | 0.01% |
90,000
-60,000
| -40% | -$2.42M |
|
1894
Old Second Bancorp
OSBC
$1.29B
| $3.3M | 0.01% |
245,202
+8,664
| +4% | +$102K |
|
1895
PRA Group
PRAA
$732M
| $3.29M | 0.01% |
+115,002
| New | +$3.84M |
|
1896
Kosmos Energy
KOS
$1.69B
| $3.29M | 0.01% |
413,770
+31,202
| +8% | +$215K |
|
|
CNCE
1897
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.29M | 0.01% |
222,819
+36,651
| +20% | +$532K |
|
|
HIMX
1898
PUT
Himax Technologies
HIMX
$2.45B
| $3.28M | 0.01% |
+300,000
| New | +$2.72M |
|
1899
Visteon
VC
$2.74B
| $3.27M | 0.01% |
26,412
-249,332
| -90% | -$28.3M |
|
1900
BWX Technologies
BWXT
$14.2B
| $3.27M | 0.01% |
58,299
-63,627
| -52% | -$3.38M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.36B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.